University of Colorado
Boulder, Colorado, 80309, United States
NCT Number: NCT02152085
The purpose of this study is to investigate the capacity of a 6-week treatment with neuromuscular electrical stimulation to improve walking in individuals whose mobility has been compromised by multiple sclerosis.
Looking for future studies?
Notify Me18 year–55 year
All sexes
Interventional
Not applicable
Boulder, Colorado, 80309, United States
Participants will be randomly assigned to one of two study arms. Those in one arm will receive a treatment with narrow stimulus pulses (0.4 ms) and those in the other arm will receive wide stimulus pulses (1 ms). The electrical stimulation will be delivered with a Vectra Genisys System.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises narrow (0.4 ms) stimulus pulses.
Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises wide (1 ms) stimulus pulses.
Time frame: Change from before to after 18 treatment sessions administered over a 6-week period (3 sessions/week).
Distance walked in 6 min
Time frame: Change from before to after 18 treatment sessions administered over a 6-week period (3 sessions/week).
MFIS scores range from 0 to 84 and higher numbers indicating worse fatigue.
Time frame: Change from before to after 18 treatment sessions administered over a 6-week period (3 sessions/week).
The time it takes to walk 25 ft
University of Colorado, Boulder
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07743281
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
East Hanover, New Jersey, United States
View Trial DetailsNCT03963375
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
St Louis, Missouri, United States
View Trial DetailsNCT02511028
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Bethesda, Maryland, United States
View Trial DetailsNCT07175792
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Diepenbeek, Belgium
View Trial Details